Lifecare AS (LIFE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 3.325x

Based on the latest financial reports, Lifecare AS (LIFE) has a cash flow conversion efficiency ratio of 3.325x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-22.15 Million ≈ $-2.33 Million USD) by net assets (Nkr-6.66 Million ≈ $-700.93K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review how financially flexible is Lifecare AS to assess the company's free cash flow relative to its total liabilities.

Lifecare AS - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Lifecare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Lifecare AS (LIFE) market capitalisation for the company's overall valuation and market capitalisation.

Lifecare AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lifecare AS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
GIGLIO.COM S.P.A. O.N.
F:5JR0
N/A
Ecoslops SA
PA:ALESA
0.259x
Meihua International Medical Technologies Co. Ltd.
NASDAQ:MHUAF
0.055x
Polar Power Inc
NASDAQ:POLA
-0.917x
Palred Technologies Limited
NSE:PALREDTEC
0.041x
Rossi Residencial S.A
SA:RSID3
-0.033x
Nala Digital Commerce Ltd
TA:SEFA
0.343x
Pantera Lithium Ltd
AU:PFE
-0.028x

Annual Cash Flow Conversion Efficiency for Lifecare AS (2017–2024)

The table below shows the annual cash flow conversion efficiency of Lifecare AS from 2017 to 2024. View LIFE stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Nkr73.98 Million
≈ $7.78 Million
Nkr-65.54 Million
≈ $-6.90 Million
-0.886x -63.52%
2023-12-31 Nkr66.45 Million
≈ $6.99 Million
Nkr-36.00 Million
≈ $-3.79 Million
-0.542x -67.72%
2022-12-31 Nkr55.25 Million
≈ $5.81 Million
Nkr-17.85 Million
≈ $-1.88 Million
-0.323x +43.13%
2021-12-31 Nkr24.25 Million
≈ $2.55 Million
Nkr-13.77 Million
≈ $-1.45 Million
-0.568x -170.03%
2020-12-31 Nkr13.33 Million
≈ $1.40 Million
Nkr-2.80 Million
≈ $-294.99K
-0.210x +50.64%
2019-12-31 Nkr15.73 Million
≈ $1.66 Million
Nkr-6.70 Million
≈ $-705.49K
-0.426x -41.36%
2018-12-31 Nkr22.24 Million
≈ $2.34 Million
Nkr-6.70 Million
≈ $-705.49K
-0.301x -110.57%
2017-12-31 Nkr-2.35 Million
≈ $-247.41K
Nkr-6.70 Million
≈ $-705.49K
2.852x --

About Lifecare AS

OL:LIFE Norway Medical Devices
Market Cap
$6.29 Million
Nkr59.80 Million NOK
Market Cap Rank
#28130 Global
#249 in Norway
Share Price
Nkr0.31
Change (1 day)
-2.19%
52-Week Range
Nkr0.28 - Nkr19.65
All Time High
Nkr95.08
About

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures … Read more